ONCOMARK
OncoMark is a UCD spin-out that develops companion diagnostic tests to support cancer drug development. Companion diagnostics allow pharmaceutical companies to select patients for which a drug may be particularly effective (patient stratification). The test can also be used during clinical trials to help reduce the numbers of patients required to complete a clinical trial and its duration, while also increasing the likelihood that the trial will be successful. The end result is improved outcome... for cancer patients. The company has a portfolio of diagnostic tests in development, covering some of the key cancer types (breast, colorectal, prostate, melanoma), supported by €3.9m in EU R&D funding. There are currently 12 employees funded through 6 grants. The company was founded by Prof. William Gallagher in UCD and is led by Dr. Mairin Rafferty, the CEO/COO. The company has a strong advisory board, which includes Prof. John Crown and Prof. Bryan Hennessy.
ONCOMARK
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2007-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.oncomark.com
Total Employee:
11+
Status:
Active
Contact:
353 1 716 3666
Email Addresses:
[email protected]
Total Funding:
5.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apache Google Apps For Business Mobile Optimized FLoC Opt-Out FLoC Drupal
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Investors List
Enterprise Ireland
Enterprise Ireland investment in Venture Round - Oncomark
Enterprise Ireland
Enterprise Ireland investment in Venture Round - Oncomark
Kernel Capital
Kernel Capital investment in Venture Round - Oncomark
Irrus Investments
Irrus Investments investment in Venture Round - Oncomark
Bank of Ireland
Bank of Ireland investment in Venture Round - Oncomark
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Oncomark
Official Site Inspections
http://www.oncomark.com
- Host name: 104.21.53.50
- IP address: 104.21.53.50
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
